LIVZON PHARMAC. GRP H YC1 (LP6) — Defensive Interval Ratio
LIVZON PHARMAC. GRP H YC1 (LP6) has a Defensive Interval Ratio of 133 days as of March 2026. Defensive assets of €2.91 Billion (cash €-, short-term investments €707.99 Million, receivables €2.20 Billion) cover 133 days of daily cash needs of €21.88 Million/day. Check LP6 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LIVZON PHARMAC. GRP H YC1 Defensive Interval Ratio (2021–2025)
This chart shows how LIVZON PHARMAC. GRP H YC1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 133 days, meaning defensive assets of €2.91 Billion can fund 133 days of operations without new revenue. Also explore LP6 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for LIVZON PHARMAC. GRP H YC1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for LIVZON PHARMAC. GRP H YC1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LIVZON PHARMAC. GRP H YC1 stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 182 days | €3.59 Billion | €19.78 Million/day | €- | €1.34 Billion | ▲ +85 days |
| 2024 | 97 days | €2.02 Billion | €20.89 Million/day | €- | €89.36 Million | ▼ -2 days |
| 2023 | 99 days | €2.20 Billion | €22.16 Million/day | €- | €81.79 Million | ▼ -25 days |
| 2022 | 125 days | €2.52 Billion | €20.26 Million/day | €- | €108.09 Million | ▲ +12 days |
| 2021 | 113 days | €2.13 Billion | €18.97 Million/day | €- | €182.77 Million | — |